top of page
Image by Solen Feyissa

Electrospinning: Our Core Technology

BioSurfaces makes devices and coatings out of FDA-approved polymers via electrospinning. These nanofibrous materials can be formed into various structures that encourage healing and treat disease at the implant site.

Next Generation Drug Delivery

BioSurfaces' room-temperature electrospinning process allows drug loading into each fiber, providing a reservoir for sustained drug release at the implant site.

About Us

We improve lives worldwide with our proprietary Bio-Spun™ nanofiber technology, leveraging decades of expertise to create superior medical devices, 3D tissue engineering scaffolds, and personal care products. Our collaborations include Takeda, NIH, and Corning.

此語言尚未有已發佈之文章
文章發佈後將於此處顯示。
bottom of page